IBB - Nasdaq Biotechnology

Description: The index is a modified capitalization weighted index that includes securities of The NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc., including a minimum market capitalization of $200 million and an average daily trading volume of at least 100,000 shares. The index is given a semi-annual ranking review to ensure that all components are still able to meet the criteria for inclusion.

Last Updated:

IBB - Profile


Summary Data for IBB

52 Week Lo: $191.00 52 Week Hi: $276.71
AUM: $5,491.9 M Shares: 20.1 M
Avg. Volume (1 month) 995,333 Avg. Volume (3 month) 1,144,508
Filings Data as of:

IBB - Holdings

Top Ten Holdings

  1. Celgene Corp CELG: 8.69%
  2. Gilead Sciences Inc GILD: 8.60%
  3. Amgen Inc AMGN: 8.38%
  4. Biogen Idec Inc BIIB: 7.99%
  5. Alexion Pharmaceuticals Inc ALXN: 6.67%
  6. Vertex Pharmaceuticals Inc VRTX: 4.69%
  7. Regeneron Pharmaceuticals Inc REGN: 3.93%
  8. Illumina Inc ILMN: 3.85%
  9. Mylan Inc MYL: 3.78%
  10. Endo International PLC ENDP: 2.33%
%Assets in Top 10: 58.90%
Total Holdings: 123.0

IBB Asset Allocation


Asset Percentage
U.S. Stocks 94.46%
International Stocks 5.45%
U.S. Bonds 0.0%
International Bonds 0.0%
Preferred Stock 0.0%
Convertibles 0.0%
Cash 0.0%
Other 0.09%

IBB Sector Breakdown


Sector Percentage
Health Care 99.91%
Financial Services 0.0%
Communication Services 0.0%
Consumer Defensive 0.0%
Real Estate 0.0%
Industrials 0.0%
Consumer Cyclical 0.0%
Basic Materials 0.0%
Energy 0.0%
Technology 0.0%
Utilities 0.0%

IBB Market Cap Breakdown


Market Cap Percentage
Giant 35.35%
Large 23.71%
Medium 21.9%
Small 9.57%
Micro 9.38%

IBB Region Breakdown


Region Percentage
U.S. 94.46%
Europe 5.38%
Asia (Emerging) 0.07%
Japan 0.0%
Australia 0.0%
Africa 0.0%
Asia (Developed) 0.0%
Latin America 0.0%
Canada 0.0%
Middle East 0.0%
Region Percentage
Developed 99.84%
Emerging 0.07%

IBB Country Breakdown


Country Percentage
United States 94.46%
United Kingdom 1.77%
Ireland 1.52%
Netherlands 1.3%
Spain 0.79%
China 0.07%
Other 0.09%
© 2014 Morningstar Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

IBB - Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Download the PDF
It appears you don't have Adobe Reader or PDF support in this web browser. Click here to download the PDF

Having trouble viewing?
Visit Adobe.com to install Adobe Acrobat Viewer.

IBB - Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of IBB relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

IBB - Fundamentals

IBB Performance

1 Week Return: 3.80%
2 Week Return: 4.99%
4 Week Return: 10.50%
13 Week Return: 15.60%
26 Week Return: 4.75%
YTD Return: 21.98%
1 Year Return: 41.47%
3 Year Return: 202.30%
5 Year Return: 255.51%

IBB Expenses & Fees

IBB Valuation

P/E Ratio: 27.89
Beta: 2.16
20 Day Moving Average: $262.35
60 Day Moving Average: $256.37

IBB Dividend

Annual Dividend Rate: $0.39
Dividend Date: 2014-06-25
Dividend: $0.39
Annual Dividend Yield %: 0.14%

IBB Volatility

5 Day Volatility: 43.39%
20 Day Volatility: 14.96%
50 Day Volatility: 20.81%
200 Day Volatility: 23.67%
Standard Deviation: 21.23%

IBB - Technicals

IBB Technicals

20 Day MA: $262.35
60 Day MA: $256.37
MACD 15 Period: 10.43
MACD 100 Period: 30.66
Williams % Range 10 Day: 1.17
Williams % Range 20 Day: 0.54
RSI 10 Day: 75
RSI 20 Day: 67
RSI 30 Day: 63
Ultimate Oscillator: 68

IBB Bollinger Bands

Lower Bollinger (10 Day): $261.66
Upper Bollinger (10 Day): $278.79
Lower Bollinger (20 Day): $243.48
Upper Bollinger (20 Day): $280.45
Lower Bollinger (30 Day): $242.11
Upper Bollinger (30 Day): $276.50

IBB Support & Resistance

Support Level 1: $274.72
Support Level 2: $272.90
Resistance Level 1: $277.50
Resistance Level 2: $278.46

IBB Stochastic

Stochastic Oscillator %D (1 Day): 67.66
Stochastic Oscillator %D (5 Day): 88.95
Stochastic Oscillator %K (1 Day): 63.79
Stochastic Oscillator %K (5 Day): 85.21

IBB Volatility

5 Day Volatility: 43.39%
20 Day Volatility: 14.96%
50 Day Volatility: 20.81%
200 Day Volatility: 23.67%
Standard Deviation: 21.23%

IBB - ETFdb Realtime Rating & Analyst Report

IBB is a passive ETF that seeks to replicate NASDAQ Biotechnology Index. The index is a modified capitalization weighted index that includes securities of The NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc., including a minimum market capitalization of $200 million and an average daily trading volume of at least 100,000 shares. The index is given a semi-annual ranking review to ensure that all components are still able to meet the criteria for inclusion.

ETFdb Category Expense Ratio Inception Date Issuer Structure YTD Return *
Health & Biotech Equities 0.48 2001-02-05 iShares ETF +21.98%

IBB Realtime Rating: By Metric

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A
Expenses B
Performance ETFdb Pro Members Only
Volatility ETFdb Pro Members Only
Dividend ETFdb Pro Members Only
Concentration ETFdb Pro Members Only

The first adjacent table gives investors an individual Realtime Rating for IBB on several different metrics, including liquidity, expenses, performance, volatility, dividend, and concentration of holdings. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities ETFdb Category with the highest Metric Realtime Rating for each individual field.

IBB Realtime Rating: Overall

ETFdb Rating Type Overall Rating A+ Overall Rated ETF
Realtime Rating (Overall) ETFdb Pro Members Only ETFdb Pro Members Only

The second table shows the overall Realtime Rating for IBB, as well as the A+ Overall Rated ETF in IBB's Category. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

ETFdb Analyst Report for IBB

This ETF offers exposure to the biotech sub-sector of the health care industry, serving up access to a group of stocks that can thrive on technological breakthroughs and increased investment in medical processes. IBB is primarily focused on U.S. stocks, though a smattering of international firms ...

Pro Membership Required to Continue Reading ETFdb Pro Members Only

To view the entire ETFdb Realtime Rating, you must be an ETFdb Pro member. To see all that is included in the ETFdb Realtime Rating, see the free previews of ten of the most popular ETFs: SPY, GLD, VWO, EFA, EEM, IVV, QQQ, TIP, VTI, LQD . Please login or begin your 14-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:

  • Register on ETFdb Get valuable insight from our analysts in the ETFdb Category reports, with in-depth breakdown every ETF niche, large or small.
  • Get portfolio guidance on nearly every possible investor scenario and include detailed information on risk profiles, asset correlation, portfolio management, and more.
  • Get access to our premium monthly newsletter ETF Edge.
  • Gain access to premium research reports covering popular sectors of the ETF industry.
  • Read in-depth monthly Q&A's with our Senior Analyst Michael Johnston.
  • Use the ETFdb Pro Screener to screen ETFs according to your own customized parameters, then download the results in Microsoft Excel format.
  • Get 100% access to the ETF Head-To-Head Comparison Tool, a resource that shows how more than 1,100 ETFs stack up against the competition in terms of performance, holdings, and technical strength.

Begin Your Free 14-Day Trial Now - or - Read more about ETFdb Pro

Latest IBB News Stories

Search ETF Database

Enter a ticker symbol or keyword: